-
Medical journals
- Career
Clinical Oncology - Issue 1/2019
Review
10Stereotactic Body Radiotherapy – Current IndicationsP. Burkoň, M. Slavik, T. Kazda, P. Pospíšil, T. Prochazka, M. Vrzal, P. Šlampa
25Is There a Benefit of HER2-Positive Breast Cancer Subtype Determination in Clinical Practice?I. Kolářová, J. Vaňásek, K. Odrážka, L. Dušek, Z. Šinkorová, A. Hlávka, J. Štuk, J. Stejskal, D. Dvořáková, L. Sákra, J. Mergancová, Z. Vilasová
31Malignant Tumors of the Penis – Diagnostics and TherapyB. Mrinakova, M. Ondrušová, M. Švantnerová, D. Ondruš
40Plasma Cell Leukemia – the Forgotten DiseaseM. Žárska, D. Vrábel, R. Bezdekova, M. Štork, M. Jarošová, Z. Adam, M. Krejčí, L. Pour, S. Ševčíková
Original Articles
47Epidemiology of Plasma Cell Leukemia in the Czech RepublicM. Zapletalova, D. Krejci, Jiří Jarkovský, J. Muzik, L. Dusek, L. Pour
52High-Dose Rate Brachytherapy in the Treatment of Early Stages of Penile CarcinomaD. Pohanková, I. Sirák, L. Kašaová, J. Grepl, P. Paluska, M. Louda, L. Holub, J. Špaček, P. Prošvic, J. Petera
58Effect of Tumor Size and p16 Status on Treatment Outcomes – Achievement of Complete Remission in Prospectively Followed Patients with Oropharyngeal TumorsM. Slavik, T. Kazda, I. Selingerová, J. Šána, P. Ahmad, D. Gurín, M. Hermanová, T. Novotný, R. Červená, R. Dymáčková, P. Burkoň, O. Slabý, P. Šlampa
66Development of Resistant GvHD in a Patient Treated with Nivolumab for Hodgkin‘s Lymphoma Relapse after Allogeneic Unrelated TransplantationK. Steinerová, P. Jindra, D. Lysák, M. Karas
Case Report
70Effective Immunotherapy of Glioblastoma in an Adolescent with Constitutional Mismatch Repair-Deficiency SyndromeZ. Pavelka, K. Zitterbart, H. Nosková, V. Bajčiová, O. Slabý, J. Štěrba
Clinical Oncology
2019 Issue 1
Most read in this issue- Malignant Tumors of the Penis – Diagnostics and Therapy
- Stereotactic Body Radiotherapy – Current Indications
- Effect of Tumor Size and p16 Status on Treatment Outcomes – Achievement of Complete Remission in Prospectively Followed Patients with Oropharyngeal Tumors
- Is There a Benefit of HER2-Positive Breast Cancer Subtype Determination in Clinical Practice?
Login#ADS_BOTTOM_SCRIPTS#Forgotten passwordEnter the email address that you registered with. We will send you instructions on how to set a new password.
- Career